Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study

作者:Xu, Dan; Yang, Ying; Yin, Zhao; Tu, Sanfang; Nie, Danian; Li, Yiqing; Huang, Zhenqian; Sun, Qixin; Huang, Changfen; Nie, Xiaqi; Yao, Zurong; Shi, Pengcheng; Zhang, Yu; Jiang, Xuejie; Liu, Qifa; Yu, Guopan*
来源:Blood Cancer Journal, 2023, 13(1): 168.
DOI:10.1038/s41408-023-00941-4
  • 单位
    中山大学; 广州医学院; 1; 南方医科大学

全文